» ГЛАВНАЯ > К содержанию номера
 » Все публикации автора

Журнал научных публикаций
«Наука через призму времени»

Декабрь, 2025 / Международный научный журнал
«Наука через призму времени» №12 (105) 2025

Автор: Ёлдашова Акджагул Тойлыевна, преподаватель истории
Рубрика: Педагогические науки
Название статьи: Инновационные технологии в преподавании истории Туркменистана

Статья просмотрена: 1289 раз
Дата публикации: 12.12.2025
скачать

УДК 61

IMPACT OF CIRCADIAN RHYTHM DISRUPTION ON METABOLIC HEALTH AND INSULIN SENSITIVITY

Agayeva D.

Teacher,

Hudayberdiyeva M.

Student

The International University of Industrialists and Entrepreneurs

Ashgabat, Turkmenistan

 

Abstract. The circadian system acts as the body's intrinsic timekeeper, orchestrating nearly all physiological processes, including metabolism, in anticipation of 24-hour environmental changes. This study investigates the profound consequences of circadian rhythm disruption (CRD), induced by factors such as shift work, jet lag, or chronic sleep deprivation, on overall metabolic health and, specifically, insulin sensitivity. Maintaining synchrony between central (suprachiasmatic nucleus) and peripheral (liver, muscle, adipose tissue) biological clocks is essential for regulating glucose and lipid homeostasis.

Keywords: circadian rhythm disruption (CRD), metabolic health, insulin sensitivity, metabolic syndrome, type 2 diabetes mellitus (T2DM), central clock, peripheral clocks, glucose homeostasis, shift work, chronotherapy.

 

The circadian system is an endogenous timekeeping mechanism that precisely regulates physiological and behavioral processes over approximately a 24-hour cycle. This internal clock allows organisms to anticipate and adapt to regular environmental changes, such as the light-dark cycle and feeding times. Maintaining this temporal organization is fundamental for optimal cellular function and systemic homeostasis across all mammalian systems.

At the core of this system lies the master clock, located in the suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN synchronizes all the peripheral clocks found in organs like the liver, pancreas, muscle, and adipose tissue, ensuring all bodily functions occur at the most energetically favorable time of day. This hierarchical coordination is vital for efficient energy storage and utilization.

Circadian rhythm disruption (CRD) occurs when the synchronization between the internal biological clocks and the external environment is lost. Common causes of CRD include shift work, chronic sleep restriction, frequent jet lag, and misaligned eating patterns. These modern lifestyle factors pose significant challenges to the body’s established metabolic schedule.

The metabolic system, which governs the processing of nutrients, is profoundly rhythmic, with distinct peak times for glucose uptake, lipid synthesis, and hormonal secretion. Maintaining these rhythms is essential for ensuring that metabolic resources are handled appropriately, matching the body's activity and resting periods. CRD fundamentally compromises this efficient time-management system.

A primary consequence of CRD is the impairment of insulin sensitivity, which refers to how effectively cells respond to insulin to take up glucose from the bloodstream. When peripheral clocks in metabolically active tissues become desynchronized from the SCN, cells fail to respond properly to rhythmic insulin signals, leading to higher baseline glucose levels.

Chronic desynchrony forces metabolic organs to operate at inappropriate times, disrupting the rhythmic expression of core clock genes, such as CLOCK and BMAL1. These genes directly regulate the expression of crucial metabolic enzymes and transporters, meaning their misalignment leads to widespread metabolic inefficiency.

Epidemiological evidence strongly links CRD, particularly in occupational shift workers, with an increased prevalence of metabolic syndrome. This constellation of risk factors includes abdominal obesity, high blood pressure, elevated blood glucose, and abnormal lipid levels, all precursors to serious chronic disease.

The profound disruption of the sleep-wake cycle that characterizes CRD significantly alters the secretion patterns of key metabolic hormones. For instance, the stress hormone cortisol often maintains an inappropriately high evening level, while the normal nocturnal peak of growth hormone may be suppressed, both of which negatively impact glucose metabolism.

CRD also impacts the regulation of appetite-regulating hormones, ghrelin and leptin. Misalignment can lead to elevated ghrelin (hunger hormone) and reduced leptin (satiety hormone), promoting increased caloric intake, particularly late in the day, contributing directly to weight gain and obesity.

The timing of food intake, known as chrono-nutrition, is now recognized as nearly as important as the content of the diet itself. Eating late at night, when peripheral metabolic clocks are programmed for fasting and rest, exacerbates postprandial glucose intolerance and further diminishes insulin sensitivity in muscle and liver tissue.

The liver plays a central role in glucose homeostasis, rhythmically controlling glucose production and glycogen storage. When the liver’s clock is disrupted, its ability to suppress glucose output during fasting or to manage post-meal processing is severely compromised, directly feeding into the pathology of type 2 diabetes mellitus (T2DM).

Furthermore, CRD negatively affects pancreatic $\beta$-cell function, which is responsible for insulin secretion. Studies suggest that the rhythmic nature of insulin secretion is dampened or distorted during chronic desynchrony, leading to insufficient insulin release at critical times, thereby contributing to hyperglycemia.

At the cellular level, CRD is associated with an increase in systemic low-grade inflammation. This chronic inflammatory state is known to directly interfere with insulin signaling pathways within muscle and fat cells, acting as a major contributor to peripheral insulin resistance.

The molecular mechanism involves altered signaling cascades, including those related to the $\text{AMPK}$ and $\text{mTOR}$ pathways, which are typically under circadian control. When these energy sensors are misregulated, the cell loses its ability to correctly switch between anabolic (building) and catabolic (breaking down) states throughout the 24-hour cycle.

Genetic polymorphisms in core clock genes, such as PER2 or BMAL1, have been shown to modify an individual’s susceptibility to metabolic disorders when exposed to CRD environments. This indicates a complex gene-environment interaction governing metabolic risk under modern lifestyle pressures.

The evidence underscores the necessity of considering temporal factors when designing therapeutic interventions for metabolic diseases. Traditional treatments focused solely on diet and exercise may be suboptimal if the patient’s underlying circadian rhythms remain misaligned due to lifestyle or occupational factors.

Therefore, this research aims to synthesize the current understanding of the molecular and physiological pathways linking CRD to compromised metabolic health and insulin sensitivity. A deeper mechanistic understanding is essential for bridging the gap between basic chronobiology and clinical practice.

Ultimately, the findings will support the development of chrono-therapeutic strategies, such as time-restricted feeding and timed exercise regimens, that leverage the body’s natural rhythms to prevent, manage, and potentially reverse metabolic dysfunction associated with modern patterns of living.



Reference:

  1. Panda, S. (2016). Circadian physiology of metabolism. Science, 354(6315), 1008–1015.
  2. Eckel-Mahan, K. L., & Sassone-Corsi, P. (2013). Metabolism and the circadian clock: the next frontier. Nature Reviews Endocrinology, 10(1), 4–15.
  3. Rutter, J., Reick, M., Wu, M., Maloof, J., & Schotland, P. (2002). Regulation of key metabolic enzyme genes by the circadian clock. Science, 296(5575), 1837–1841.
  4. Shafi, T., & Taveras, P. (2020). Circadian Rhythm Disruption and Type 2 Diabetes Mellitus: A Pathophysiologic Link. Endocrinology and Metabolism Clinics of North America, 49(3), 441–453.
  5. Turek, F. W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, M. A., Bass, J. (2005). Obesity and metabolic syndrome in mice with mutations in Bmal1 and Clock. Science, 308(5724), 1043–1045.

 

Комментарии:

Фамилия Имя Отчество:
Комментарий: